Category Europe

Partnership To Share Research, Keep IP Rights, On Neglected Diseases

The Drugs for Neglected Diseases initiative (DNDi) signed an agreement with pharmaceutical manufacturer Sanofi on 30 May for a three-year research project on nine neglected tropical diseases that will come with intellectual property rights on research results for both sides, according to a press release from the international organisation in Switzerland.

Proposed EU Customs Regulation May Not Dispel Fear Of Wrongful Drug Seizures

The European Commission has issued a new draft customs regulation that it says addresses past concerns over wrongful seizures of generic drug shipments transiting through European ports. But the new regulation does not substantively change existing rules, it said, and civil society groups say it does not go far enough. The EU regulation is the subject of a World Trade Organization dispute settlement case.

G8 Highlights Internet, IP Rights, Innovation, WIPO

Leaders of the Group of Eight industrialised countries today concluded their annual meeting, this year held in Deauville, France, with a communiqué bearing extensive discussion of the internet, intellectual property rights, and innovation - and a call for the World Intellectual Property Organization to step up work. In fact, it had a lot more to say about these issues than it did about the global economy or trade.